Diabetes is a global epidemic that has no known cure. Developing an “exercise pill” that enhances muscle-glucose handling represents a novel approach to treat diabetes. Our core technology builds upon the discovery of a muscle-specific gene that transduces the exercise benefits to glucose handling in diabetes and age-related decline of metabolic function.